Repositive
Human genome research platform
Repositive has raised €2.9M across 1 funding round from 4 investors, most recently a Series A round in Apr 2017. Based in UK; active in Software and Healthtech. Data as of 4 Nov 2026.
Total raised
€2.9M
€2,919,776
Funding rounds
1
Investors
4
distinct backers
Active since
2017-04
latest 2017-04
Funding by year
EUR raised per yearRepositive — funding by year — interactive chart.
Data table
| Repositive — funding by year | |
|---|---|
| 2017 | €2.9M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-04-05 | Series A | €2.9M | Amadeus Capital Partners,Ananda Ventures,Force Over Mass Capital,Jonathan Milner | View deal → |
Related news
Similar companies
same sector, similar size- WhenFresh€3.4MUK · Software
- Symphony Ventures€3.5MUK · Software
- Echobox€3.0MUK · Software
- YellowDog€2.8MUK · Software
- Smartology€3.1MUK · Software
- Cronycle€2.4MUK · Software
Global coverage: FundingData